Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Benzer Materyaller

• TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
  Yazar:: Angus, B, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Chronic lung disease in HIV-infected children established on antiretroviral therapy
  Yazar:: Rylance, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
  Yazar:: Gossez, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
  Yazar:: Lewis, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Treatment interruption in chronic HIV-1 infection: does it deliver?
  Yazar:: Willberg, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)